Beijing Pinxin Pharma Technology Development

Beijing Pinxin Pharma Technology Development is a specialized biotechnology company focused on the development of complex, high-barrier drug delivery systems. Headquartered in Beijing, the company leverages its proprietary long-acting microsphere and liposome technology platforms to create improved versions of established therapeutics, particularly in the fields of psychiatry, endocrinology, and oncology. Pinxin Pharma provides both internal R&D for its own pipeline and contract research services for complex formulation development. Their lead programs include long-acting injectable formulations of risperidone and octreotide designed to enhance patient adherence and therapeutic outcomes.